首页 > 最新文献

Acta bio-medica : Atenei Parmensis最新文献

英文 中文
Not only enuresis: do not disregard organic disorders. 不仅是遗尿症:不要忽视器质性疾病。
Pub Date : 2023-12-05 DOI: 10.23750/abm.v94i6.14931
Pietro Ferrara, Giovanna Magli, Elena Malavolta, Emidio Procaccini, Luca Massimi, Antonio Gatto

Nocturnal enuresis (NE) is a common condition in the pediatric age. NE is defined as an intermittent bedwetting with any frequency while sleeping in children. NE is classified into primary form (patient never had achieved nocturnal urinary control) or secondary form (children with a period of 6 consecutive months of night-time urinary control before incontinence, which is generally associated with organic or psychological causes). Moreover, NE could be monosymptomatic (MNE) or non-monosymptomatic (NMNE), depending on the presence of daytime incontinence or any other lower urinary tract symptoms (LUTS). We report a 7-year- old female with a history of recent onset of sphincter troubles and recurrent low urinary tract infections. She presented urinary urgency associated to daytime incontinence, bedwetting almost every night in the previous 3 months and sometimes encopresis. The physical and neurological examination was silent, no psychological or social problem intercurred. As first approach, she was treated with deamino-delta-D-arginine vasopressin (dDAVP) 120 mcg associated with oxybutynin 5 mg and educational therapy, for 3 months without benefits. So, she underwent a magnetic resonance imaging (MRI) of the spinal cord, that highlighted the presence of hydrosyringomyelia from D6 to D10, lipoma of the terminal filum and the presence of synovial cyst between L5-S1. This case remarks that in secondary NMNE, any possible organic cause must be investigated.

夜间遗尿症(NE)是儿科常见疾病。夜尿症的定义是儿童在睡觉时以任何频率间歇性尿床。夜尿症可分为原发性夜尿症(患者从未控制过夜尿)和继发性夜尿症(儿童在尿失禁前已连续 6 个月控制夜尿,通常与器质性或心理性原因有关)。此外,根据是否存在日间尿失禁或其他下尿路症状(LUTS),夜尿症可能是单症状(MNE)或非单症状(NMNE)。我们报告了一名 7 岁女性的病例,她最近出现了括约肌问题和反复低位尿路感染。她有尿急和白天尿失禁的症状,在过去的三个月中几乎每晚都尿床,有时还会出现遗尿。体格检查和神经系统检查均无异常,也没有出现任何心理或社会问题。首先,她接受了去氨-δ-D-精氨酸加压素(dDAVP)120微克和奥昔布宁5毫克的治疗,并接受了教育治疗,但3个月后仍未见效。因此,她接受了脊髓磁共振成像(MRI)检查,结果显示 D6 至 D10 存在水肿性脊髓脊膜膨出、末端丝状脂肪瘤以及 L5-S1 之间存在滑膜囊肿。该病例说明,对于继发性颅内压增高症,必须对任何可能的器质性病因进行调查。
{"title":"Not only enuresis: do not disregard organic disorders.","authors":"Pietro Ferrara, Giovanna Magli, Elena Malavolta, Emidio Procaccini, Luca Massimi, Antonio Gatto","doi":"10.23750/abm.v94i6.14931","DOIUrl":"10.23750/abm.v94i6.14931","url":null,"abstract":"<p><p>Nocturnal enuresis (NE) is a common condition in the pediatric age. NE is defined as an intermittent bedwetting with any frequency while sleeping in children. NE is classified into primary form (patient never had achieved nocturnal urinary control) or secondary form (children with a period of 6 consecutive months of night-time urinary control before incontinence, which is generally associated with organic or psychological causes). Moreover, NE could be monosymptomatic (MNE) or non-monosymptomatic (NMNE), depending on the presence of daytime incontinence or any other lower urinary tract symptoms (LUTS). We report a 7-year- old female with a history of recent onset of sphincter troubles and recurrent low urinary tract infections. She presented urinary urgency associated to daytime incontinence, bedwetting almost every night in the previous 3 months and sometimes encopresis. The physical and neurological examination was silent, no psychological or social problem intercurred. As first approach, she was treated with deamino-delta-D-arginine vasopressin (dDAVP) 120 mcg associated with oxybutynin 5 mg and educational therapy, for 3 months without benefits. So, she underwent a magnetic resonance imaging (MRI) of the spinal cord, that highlighted the presence of hydrosyringomyelia from D6 to D10, lipoma of the terminal filum and the presence of synovial cyst between L5-S1. This case remarks that in secondary NMNE, any possible organic cause must be investigated.</p>","PeriodicalId":93849,"journal":{"name":"Acta bio-medica : Atenei Parmensis","volume":"94 6","pages":"e2023223"},"PeriodicalIF":0.0,"publicationDate":"2023-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10734227/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138489335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anti-recoverin antibodies in a cerebellar syndrome without retinal involvement. 无视网膜受累的小脑综合征中的抗复原素抗体。
Pub Date : 2023-12-05 DOI: 10.23750/abm.v94i6.15234
Matteo Minetti, Giulia Balella, Lucia Zinno

Anti-recoverin antibodies are typically found in cancer-associated retinopathy or autoimmune diseases. We present a case of anti-recoverin positive cerebellar syndrome without any signs of malignancy or retinopathy. The patient was treated with steroids and intravenous immunoglobulins, resulting in improvements in both cognitive and motor symptoms.

抗再造素抗体通常出现在癌症相关性视网膜病变或自身免疫性疾病中。我们介绍了一例抗再造素抗体阳性的小脑综合征患者,该患者没有任何恶性肿瘤或视网膜病变的迹象。患者接受了类固醇和静脉注射免疫球蛋白治疗,认知和运动症状均有所改善。
{"title":"Anti-recoverin antibodies in a cerebellar syndrome without retinal involvement.","authors":"Matteo Minetti, Giulia Balella, Lucia Zinno","doi":"10.23750/abm.v94i6.15234","DOIUrl":"10.23750/abm.v94i6.15234","url":null,"abstract":"<p><p>Anti-recoverin antibodies are typically found in cancer-associated retinopathy or autoimmune diseases. We present a case of anti-recoverin positive cerebellar syndrome without any signs of malignancy or retinopathy. The patient was treated with steroids and intravenous immunoglobulins, resulting in improvements in both cognitive and motor symptoms.</p>","PeriodicalId":93849,"journal":{"name":"Acta bio-medica : Atenei Parmensis","volume":"94 6","pages":"e2023258"},"PeriodicalIF":0.0,"publicationDate":"2023-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10734245/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138489263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antibiotic treatment for streptococcal pharyngitis: time for a new approach? 链球菌性咽炎的抗生素治疗:是时候采用新方法了吗?
Pub Date : 2023-12-05 DOI: 10.23750/abm.v94i6.14928
Lorenzo Di Sarno, Antonietta Curatola, Valeria Pansini, Anya Caroselli, Antonio Gatto, Antonio Chiaretti

.

.
{"title":"Antibiotic treatment for streptococcal pharyngitis: time for a new approach?","authors":"Lorenzo Di Sarno, Antonietta Curatola, Valeria Pansini, Anya Caroselli, Antonio Gatto, Antonio Chiaretti","doi":"10.23750/abm.v94i6.14928","DOIUrl":"10.23750/abm.v94i6.14928","url":null,"abstract":"<p><p>.</p>","PeriodicalId":93849,"journal":{"name":"Acta bio-medica : Atenei Parmensis","volume":"94 6","pages":"e2023219"},"PeriodicalIF":0.0,"publicationDate":"2023-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10734236/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138489262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcome of simultaneous bi-unicompartmental knee arthroplasty: a systematic review. 同步双双室膝关节置换术的效果:系统性综述。
Pub Date : 2023-12-05 DOI: 10.23750/abm.v94i6.15006
Ibrahim Akkawi, Maurizio Draghetti, Hassan Zmerly

Background and aim: Simultaneous medial and lateral tibiofemoral osteoarthritis (OA) could be treated with bi-unicompartmental knee arthroplasty (Bi-UKA) as an alternative to total knee arthroplasty (TKA). The present systematic review aims to assess if simultaneous Bi-UKA is a feasible option for treating medial and lateral tibiofemoral OA.

Materials and methods: A comprehensive search of PubMed, MEDLINE, Cochrane Library, and Google Scholar was performed to find studies that reported on the outcome of simultaneous Bi-UKA for both medial and lateral tibiofemoral OA.

Results: Seven studies were considered eligible for inclusion in the present systematic review. Intraoperative fractures occurred 8 times. Overall, there were 22 revisions of the prosthetic components for any reason with a survival rate that ranged from 83 to 100%. Of these, 16 revisions were for the aseptic loosening of the prosthetic components. Out of 302 surgeries, three were revised due to symptomatic OA progression in the patello-femoral joint. All clinical scores improved at the latest follow-up compared to preoperative values. Moreover, there were no differences in clinical scores of Bi-UKA compared to unicompartmental knee arthroplasty (UKA), or medial UKA plus patello-femoral prosthesis. Whereas, compared to TKA, Bi-UKA patients had comparable or superior scores. Finally, the Bi-UKA group had a significantly shorter hospital stay compared to the TKA group.

Conclusions: The use of simultaneous Bi-UKA is a valid option to address bicompartmental knee OA in selected patients with low intraoperative fracture rate, low revision rate, satisfactory clinical outcome, and fast recovery.

背景和目的:作为全膝关节置换术(TKA)的替代方案,双膝单隔间室膝关节置换术(Bi-UKA)可同时治疗胫骨内侧和外侧骨关节炎(OA)。本系统性综述旨在评估同时进行 Bi-UKA 是否是治疗胫骨股骨内侧和外侧 OA 的可行方案:对PubMed、MEDLINE、Cochrane Library和Google Scholar进行了全面检索,以找到报道同步Bi-UKA治疗内侧和外侧胫骨骨关节OA结果的研究:有七项研究被认为符合纳入本系统综述的条件。术中骨折发生了8次。总体而言,共有22例因任何原因进行的假体部件翻修,存活率从83%到100%不等。其中,16次翻修是因为假体组件无菌性松动。在302例手术中,有3例是因为髌骨-股骨关节有症状的OA进展而进行的翻修。在最近一次随访中,所有临床评分均比术前有所改善。此外,与单室膝关节置换术(UKA)或内侧UKA加髌股关节假体相比,Bi-UKA的临床评分没有差异。而与 TKA 相比,Bi-UCA 患者的评分相当或更高。最后,Bi-UKA组的住院时间明显短于TKA组:结论:对经过选择的患者来说,使用同步 Bi-UKA 是治疗双室膝关节 OA 的有效选择,术中骨折率低、翻修率低、临床效果满意且恢复快。
{"title":"Outcome of simultaneous bi-unicompartmental knee arthroplasty: a systematic review.","authors":"Ibrahim Akkawi, Maurizio Draghetti, Hassan Zmerly","doi":"10.23750/abm.v94i6.15006","DOIUrl":"10.23750/abm.v94i6.15006","url":null,"abstract":"<p><strong>Background and aim: </strong>Simultaneous medial and lateral tibiofemoral osteoarthritis (OA) could be treated with bi-unicompartmental knee arthroplasty (Bi-UKA) as an alternative to total knee arthroplasty (TKA). The present systematic review aims to assess if simultaneous Bi-UKA is a feasible option for treating medial and lateral tibiofemoral OA.</p><p><strong>Materials and methods: </strong>A comprehensive search of PubMed, MEDLINE, Cochrane Library, and Google Scholar was performed to find studies that reported on the outcome of simultaneous Bi-UKA for both medial and lateral tibiofemoral OA.</p><p><strong>Results: </strong>Seven studies were considered eligible for inclusion in the present systematic review. Intraoperative fractures occurred 8 times. Overall, there were 22 revisions of the prosthetic components for any reason with a survival rate that ranged from 83 to 100%. Of these, 16 revisions were for the aseptic loosening of the prosthetic components. Out of 302 surgeries, three were revised due to symptomatic OA progression in the patello-femoral joint. All clinical scores improved at the latest follow-up compared to preoperative values. Moreover, there were no differences in clinical scores of Bi-UKA compared to unicompartmental knee arthroplasty (UKA), or medial UKA plus patello-femoral prosthesis. Whereas, compared to TKA, Bi-UKA patients had comparable or superior scores. Finally, the Bi-UKA group had a significantly shorter hospital stay compared to the TKA group.</p><p><strong>Conclusions: </strong>The use of simultaneous Bi-UKA is a valid option to address bicompartmental knee OA in selected patients with low intraoperative fracture rate, low revision rate, satisfactory clinical outcome, and fast recovery.</p>","PeriodicalId":93849,"journal":{"name":"Acta bio-medica : Atenei Parmensis","volume":"94 6","pages":"e2023240"},"PeriodicalIF":0.0,"publicationDate":"2023-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10734244/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138489337","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between severity of sepsis and thyroid function profile. 败血症严重程度与甲状腺功能状况之间的关系
Pub Date : 2023-12-05 DOI: 10.23750/abm.v94i6.15076
Vindy Nugraha Siampa, Satriawan Abadi, Andi Makbul Aman, Syakib Bakri, Risna Halim, Andi Alfian Zainuddin

Background and aim: Critical illness conditions such as sepsis are often accompanied by altered hormone levels, which may result in decreased thyroid axis activity. This condition aims to provide metabolic substrates for vital organs such as the brain and immune system. Significant alteration of the thyroid axis in critical illnesses such as sepsis known as Low-T3 Syndrome which is associated with increased mortality. This study aims to determine the association between severity of sepsis and thyroid function profile as a predictor of mortality in sepsis patients.

Methods: An observational study involving 62 subjects with sepsis and septic shock. Serum was measured using Enzyme-linked Immunosorbent Assay (ELISA) method. Statistical analysis used Mann-Whitney, Kruskal-Wallis, and Spearman's correlation tests. Statistical test results are significant if the p-value <0.05.

Results: The median fT3 level was lower in the septic shock group 13.94 pg/ml (7.71-19.93) compared to the sepsis group 20.15 pg/ml (11.08-37.15) where there was a significant difference (p<0.001). There was a significant correlation between The Sequential Organ Failure Assessment (SOFA) score and fT3 levels (R: -0.270, p=0.032). The non-survivor group had a lower median fT3 level 16.56 pg/ml (7.71-30.03) compared to the survivor group 17.50 pg/ml (10.32-37.15) where there was a significant difference (p<0.036).

Conclusion: Based on the severity of sepsis, the more severe the sepsis condition, the lower thyroid function levels are obtained where decreased thyroid function levels can be a prognosis indicator to predict mortality in sepsis patients.

背景和目的:脓毒症等重症疾病往往伴随着激素水平的改变,这可能会导致甲状腺轴活性降低。这种情况旨在为大脑和免疫系统等重要器官提供代谢基质。甲状腺轴在败血症等危重病中的显著变化被称为低T3综合征,与死亡率增加有关。本研究旨在确定败血症的严重程度与甲状腺功能状况之间的关联,并以此作为预测败血症患者死亡率的指标:这项观察性研究涉及 62 名脓毒症和脓毒性休克患者。采用酶联免疫吸附试验(ELISA)法测定血清。统计分析采用 Mann-Whitney、Kruskal-Wallis 和 Spearman 相关性检验。统计检验结果以 p 值为显着结果:脓毒性休克组的 fT3 水平中位数为 13.94 pg/ml(7.71-19.93),低于脓毒症组的 20.15 pg/ml(11.08-37.15),差异有显著性(pConclusion):根据脓毒症的严重程度,脓毒症病情越严重,甲状腺功能水平越低,甲状腺功能水平下降可作为预测脓毒症患者死亡率的预后指标。
{"title":"Association between severity of sepsis and thyroid function profile.","authors":"Vindy Nugraha Siampa, Satriawan Abadi, Andi Makbul Aman, Syakib Bakri, Risna Halim, Andi Alfian Zainuddin","doi":"10.23750/abm.v94i6.15076","DOIUrl":"10.23750/abm.v94i6.15076","url":null,"abstract":"<p><strong>Background and aim: </strong>Critical illness conditions such as sepsis are often accompanied by altered hormone levels, which may result in decreased thyroid axis activity. This condition aims to provide metabolic substrates for vital organs such as the brain and immune system. Significant alteration of the thyroid axis in critical illnesses such as sepsis known as Low-T3 Syndrome which is associated with increased mortality. This study aims to determine the association between severity of sepsis and thyroid function profile as a predictor of mortality in sepsis patients.</p><p><strong>Methods: </strong>An observational study involving 62 subjects with sepsis and septic shock. Serum was measured using Enzyme-linked Immunosorbent Assay (ELISA) method. Statistical analysis used Mann-Whitney, Kruskal-Wallis, and Spearman's correlation tests. Statistical test results are significant if the p-value <0.05.</p><p><strong>Results: </strong>The median fT3 level was lower in the septic shock group 13.94 pg/ml (7.71-19.93) compared to the sepsis group 20.15 pg/ml (11.08-37.15) where there was a significant difference (p<0.001). There was a significant correlation between The Sequential Organ Failure Assessment (SOFA) score and fT3 levels (R: -0.270, p=0.032). The non-survivor group had a lower median fT3 level 16.56 pg/ml (7.71-30.03) compared to the survivor group 17.50 pg/ml (10.32-37.15) where there was a significant difference (p<0.036).</p><p><strong>Conclusion: </strong>Based on the severity of sepsis, the more severe the sepsis condition, the lower thyroid function levels are obtained where decreased thyroid function levels can be a prognosis indicator to predict mortality in sepsis patients.</p>","PeriodicalId":93849,"journal":{"name":"Acta bio-medica : Atenei Parmensis","volume":"94 6","pages":"e2023239"},"PeriodicalIF":0.0,"publicationDate":"2023-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10734233/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138489265","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dyspepsia in the middle ages: a reference in Giovanni Boccaccio's Decameron (14th century AD)? 中世纪的消化不良:乔瓦尼-薄伽丘的《十日谈》(公元 14 世纪)中的参考文献?
Pub Date : 2023-12-05 DOI: 10.23750/abm.v94i6.15137
Francesco Maria Galassi, Giovanni Spani, Michael Papio, Fabrizio Toscano, Marco Artico, Elena Varotto

.

.
{"title":"Dyspepsia in the middle ages: a reference in Giovanni Boccaccio's Decameron (14th century AD)?","authors":"Francesco Maria Galassi, Giovanni Spani, Michael Papio, Fabrizio Toscano, Marco Artico, Elena Varotto","doi":"10.23750/abm.v94i6.15137","DOIUrl":"10.23750/abm.v94i6.15137","url":null,"abstract":"<p><p>.</p>","PeriodicalId":93849,"journal":{"name":"Acta bio-medica : Atenei Parmensis","volume":"94 6","pages":"e2023237"},"PeriodicalIF":0.0,"publicationDate":"2023-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10734224/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138489292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term health consequences of central precocious/early puberty (CPP) and treatment with Gn-RH analogue: a short update. 中枢性性早熟(CPP)和 Gn-RH 类似物治疗对健康的长期影响:简短更新。
Pub Date : 2023-12-05 DOI: 10.23750/abm.v94i6.15316
Ashraf T Soliman, Nada Alaaraj, Vincenzo De Sanctis, Noor Hamed, Fawzia Alyafei, Shayma Ahmed

Background: The relationship between precocious or early puberty and its treatment has received significant research attention, yielding diverse outcomes. This short review aims to comprehensively analyze and summarize research articles to elucidate the potential link between precocious or early pubertal onset (CPP) and crucial health factors.

Methods: We conducted a systematic review of studies published from -January 2000 to March 2023, sourced from databases of Medline, PubMed, Google Scholar and Web of Science. We assessed the relationship between CPP and final adult height (FHt), bone health, reproductive function, body mass index, metabolic and cardiovascular abnormalities, and increased cancer risk.

Results: Upon reviewing and analyzing selected studies, the following key findings emerged: (a) treating CPP in girls before age 6-7 and in boys before age 9 improves FHt; (b) bone mineral density (BMD) decreases during GnRHa treatment but normalizes afterward, with no lasting effects on peak bone mass during puberty; (c) GnRH treatment does not negatively affect menstrual cycles; however, untreated CPP increases the risk of premature or early-onset menopause; (d) the incidence of PCOS/hyperandrogenemia may be slightly elevated in women with a history of CPP, but overall reproductive function remains largely unaffected; (e) earlier thelarche and menarche may enhance susceptibility to breast carcinogenesis; (f) CPP contributes to an increased risk of obesity and type 2 diabetes in both genders; (g) early menarche may slightly increase the risk of coronary heart disease and ischemic strokes and (h) early pubertal timing increases the risk of depression and anxiety disorders.

Conclusion: Monitoring and early diagnosis of these conditions are of paramount importance for successful management.

背景:性早熟或青春期过早与治疗之间的关系受到了大量研究的关注,并产生了不同的结果。本简短综述旨在全面分析和总结研究文章,以阐明性早熟或青春期提前(CPP)与关键健康因素之间的潜在联系:我们对 2000 年 1 月至 2023 年 3 月期间发表的研究进行了系统性回顾,这些研究来自 Medline、PubMed、Google Scholar 和 Web of Science 等数据库。我们评估了 CPP 与成人最终身高(FHt)、骨骼健康、生殖功能、体重指数、代谢和心血管异常以及癌症风险增加之间的关系:在回顾和分析所选研究后,得出以下主要结论:(a) 对 6-7 岁前的女孩和 9 岁前的男孩进行 CPP 治疗可改善 FHt;(b) 在 GnRHa 治疗期间,骨矿物质密度(BMD)会下降,但治疗后会恢复正常,对青春期峰值骨量不会产生持久影响;(c) GnRH 治疗不会对月经周期产生负面影响;但未经治疗的 CPP 会增加过早绝经或提前绝经的风险;(d) 有 CPP 病史的妇女患多囊卵巢综合症/高雄激素血症的几率可能略有上升,但总体生殖功能基本不受影响; (e) 初潮和月经初潮提前可能会增加乳腺癌的易感性;(h) 青春期提前会增加患抑郁症和焦虑症的风险。结论对这些情况进行监测和早期诊断对于成功管理至关重要。
{"title":"Long-term health consequences of central precocious/early puberty (CPP) and treatment with Gn-RH analogue: a short update.","authors":"Ashraf T Soliman, Nada Alaaraj, Vincenzo De Sanctis, Noor Hamed, Fawzia Alyafei, Shayma Ahmed","doi":"10.23750/abm.v94i6.15316","DOIUrl":"10.23750/abm.v94i6.15316","url":null,"abstract":"<p><strong>Background: </strong>The relationship between precocious or early puberty and its treatment has received significant research attention, yielding diverse outcomes. This short review aims to comprehensively analyze and summarize research articles to elucidate the potential link between precocious or early pubertal onset (CPP) and crucial health factors.</p><p><strong>Methods: </strong>We conducted a systematic review of studies published from -January 2000 to March 2023, sourced from databases of Medline, PubMed, Google Scholar and Web of Science. We assessed the relationship between CPP and final adult height (FHt), bone health, reproductive function, body mass index, metabolic and cardiovascular abnormalities, and increased cancer risk.</p><p><strong>Results: </strong>Upon reviewing and analyzing selected studies, the following key findings emerged: (a) treating CPP in girls before age 6-7 and in boys before age 9 improves FHt; (b) bone mineral density (BMD) decreases during GnRHa treatment but normalizes afterward, with no lasting effects on peak bone mass during puberty; (c) GnRH treatment does not negatively affect menstrual cycles; however, untreated CPP increases the risk of premature or early-onset menopause; (d) the incidence of PCOS/hyperandrogenemia may be slightly elevated in women with a history of CPP, but overall reproductive function remains largely unaffected; (e) earlier thelarche and menarche may enhance susceptibility to breast carcinogenesis; (f) CPP contributes to an increased risk of obesity and type 2 diabetes in both genders; (g) early menarche may slightly increase the risk of coronary heart disease and ischemic strokes and (h) early pubertal timing increases the risk of depression and anxiety disorders.</p><p><strong>Conclusion: </strong>Monitoring and early diagnosis of these conditions are of paramount importance for successful management.</p>","PeriodicalId":93849,"journal":{"name":"Acta bio-medica : Atenei Parmensis","volume":"94 6","pages":"e2023222"},"PeriodicalIF":0.0,"publicationDate":"2023-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10734238/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138489297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Open Technique. 开放技术。
Pub Date : 2023-10-17 DOI: 10.23750/abm.v94i5.13541
Renato Costi, Manuel Baldinu, Filippo Montali, Alfredo Annicchiarico

.

{"title":"Open Technique.","authors":"Renato Costi, Manuel Baldinu, Filippo Montali, Alfredo Annicchiarico","doi":"10.23750/abm.v94i5.13541","DOIUrl":"10.23750/abm.v94i5.13541","url":null,"abstract":"<p><p>.</p>","PeriodicalId":93849,"journal":{"name":"Acta bio-medica : Atenei Parmensis","volume":"94 5","pages":"e2023231"},"PeriodicalIF":0.0,"publicationDate":"2023-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644925/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41242022","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical and epidemiological features and therapeutic options of avascular necrosis in patients with sickle cell disease (SCD): a cross-sectional study. 镰状细胞病(SCD)患者缺血性坏死的临床和流行病学特征及治疗选择:一项横断面研究。
Pub Date : 2023-10-17 DOI: 10.23750/abm.v94i5.14603
Awni Alshurafa, Ashraf T Soliman, Vincenzo De Sanctis, Omar Ismail, Mohammad Abu-Tineh, Mohammad Khair Eddin Hemadneh, Farah Rahat Rashid, Khadra Yassin, Hana Qasim, Abdulqadir Jeprel Nashwan, Mohamed A Yassin

Background: Avascular necrosis (AVN) is a debilitating complication in sickle cell disease (SCD) patients, and its management is usually challenging. This study aims to evaluate the clinical and epidemiological features and therapeutic options of AVN in sickle cell patients in Qatar.

Patients and methods: A cross-sectional study was conducted on a 49 SCD patients who were diagnosed with AVN and attended the hematology clinic at the National Center for Cancer care & research, Hamad Medical Corporation, Qatar between Jan-2011 to Jan2021.  Results: Forty-nine adult patients with SCD who were diagnosed with AVN were studied. The median age of the study population is 32 years, and the median age at the first AVN diagnosis was 26 years (range: 11-44 yr.). 37 (75.5%) patients suffered from multiple joints AVN while 12(24.5%) had single joint involvement. 31 (63.3%) patients had bilateral hip AVN and 18 (36.7%) had shoulder involvement. 30 patients (61%) were on Hydroxyurea treatment. Based on FICAT and Alert classification of AVN, 57 % of patients had stage III and above at first diagnosis. 20 (40.8%) were managed with a conservative approach, 11 (22.4%) received hyperbaric oxygen with good response, 6(12.2%) underwent hip core decompression and 12(24.5%) underwent hip replacement surgery.

Conclusion: In SCD patients, AVN occurred more during the 3rd and 4th decades of life. The majority of AVN represented with advanced stage and had multiple joint involvements. We recommend adopting a low threshold of joint imaging for early detection and prevention of further complications.

背景:缺血性坏死(AVN)是镰状细胞病(SCD)患者的一种使人衰弱的并发症,其治疗通常具有挑战性。本研究旨在评估卡塔尔镰状细胞病患者AVN的临床和流行病学特征以及治疗选择。患者和方法:对49名SCD患者进行横断面研究,这些患者在2011年1月至2021年1月期间被诊断为AVN,并在卡塔尔哈马德医疗公司癌症护理与研究中心的血液科诊所就诊。结果:对49例诊断为AVN的成人SCD患者进行了研究。研究人群的中位年龄为32岁,首次诊断AVN的中位年纪为26岁(范围:11-44岁)。37名(75.5%)患者患有多关节AVN,12名(24.5%)患者患有单关节AVN。31例(63.3%)患者有双侧髋关节AVN,18例(36.7%)患者有肩部受累。30名患者(61%)接受羟基脲治疗。根据FICAT和AVN的Alert分类,57%的患者在首次诊断时具有III期及以上。20例(40.8%)采用保守治疗,11例(22.4%)接受高压氧治疗,反应良好,6例(12.2%)接受髋核心减压,12例(24.5%)接受全髋关节置换手术。结论:在SCD患者中,AVN发生在生命的第3和第4个十年。大多数AVN表现为晚期,并有多个关节受累。我们建议采用低阈值的关节成像,以早期发现并预防进一步的并发症。
{"title":"Clinical and epidemiological features and therapeutic options of avascular necrosis in patients with sickle cell disease (SCD): a cross-sectional study.","authors":"Awni Alshurafa, Ashraf T Soliman, Vincenzo De Sanctis, Omar Ismail, Mohammad Abu-Tineh, Mohammad Khair Eddin Hemadneh, Farah Rahat Rashid, Khadra Yassin, Hana Qasim, Abdulqadir Jeprel Nashwan, Mohamed A Yassin","doi":"10.23750/abm.v94i5.14603","DOIUrl":"10.23750/abm.v94i5.14603","url":null,"abstract":"<p><strong>Background: </strong>Avascular necrosis (AVN) is a debilitating complication in sickle cell disease (SCD) patients, and its management is usually challenging. This study aims to evaluate the clinical and epidemiological features and therapeutic options of AVN in sickle cell patients in Qatar.</p><p><strong>Patients and methods: </strong>A cross-sectional study was conducted on a 49 SCD patients who were diagnosed with AVN and attended the hematology clinic at the National Center for Cancer care & research, Hamad Medical Corporation, Qatar between Jan-2011 to Jan2021.  Results: Forty-nine adult patients with SCD who were diagnosed with AVN were studied. The median age of the study population is 32 years, and the median age at the first AVN diagnosis was 26 years (range: 11-44 yr.). 37 (75.5%) patients suffered from multiple joints AVN while 12(24.5%) had single joint involvement. 31 (63.3%) patients had bilateral hip AVN and 18 (36.7%) had shoulder involvement. 30 patients (61%) were on Hydroxyurea treatment. Based on FICAT and Alert classification of AVN, 57 % of patients had stage III and above at first diagnosis. 20 (40.8%) were managed with a conservative approach, 11 (22.4%) received hyperbaric oxygen with good response, 6(12.2%) underwent hip core decompression and 12(24.5%) underwent hip replacement surgery.</p><p><strong>Conclusion: </strong>In SCD patients, AVN occurred more during the 3rd and 4th decades of life. The majority of AVN represented with advanced stage and had multiple joint involvements. We recommend adopting a low threshold of joint imaging for early detection and prevention of further complications.</p>","PeriodicalId":93849,"journal":{"name":"Acta bio-medica : Atenei Parmensis","volume":"94 5","pages":"e2023198"},"PeriodicalIF":0.0,"publicationDate":"2023-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644931/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41242008","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of genotypic and phenotypic antimicrobial profile in carbapenemases producing Klebsiella pneumoniae. 产碳青霉烯酶肺炎克雷伯菌的基因型和表型抗菌谱的比较。
Pub Date : 2023-10-17 DOI: 10.23750/abm.v94i5.14412
Arcadia Del Rio, Mariangela Puci, Narcisa Muresu, Illari Sechi, Laura Saderi, Luigi Cugia, Giovanni Sotgiu, Andrea Piana

Background and aim: Prompt administration of appropriate antibiotic therapy is crucial in improving outcomes, particularly in cases sustained by multi-drug resistant strains. Although phenotypic antimicrobial susceptibility testing (AST) represents the gold standard to address antibiotics treatment, the long time required to obtained affordable results could negatively affect the prognosis. In contrast, rapid genotypic AST provide essential information for treatment and surveillance program. In order to evaluate the potential adoption of rapid AST in clinical routine, we compared the genotypic and phenotypic antimicrobial profiles of different K.pneumoniae strains, characterized by different expression of carbapenemases-encoding genes.

Methods: A set of 109 strains of Cr-Kp were tested for the antimicrobial drugs by the automatized Vitek II system and, in parallel, to the new combination of β-lactams/β-lactamases inhibitors (BL/BLI) by Etest. An antimicrobial resistance index (ARI) was calculated for each strain, assigning each 1 or 0 points based on observed resistance/susceptibility, and dividing the total by the number of antibiotics tested. Kruskal-Wallis test, followed by Dunn's post hoc test (Bonferroni correction), were used to compare quantitative variables among resistance gene subgroups.

Results: We observed a higher ARI score in KPC/OXA-48 strains, similar profile in KPC alone and KPC/CTX-M groups and a significant lower resistance in no-carbapenemases-producing group. Same trend was observed in AST for BL/BLI.

Conclusions: These preliminary results showed a close link between genotypic and phenotypic AST, supporting the adoption of rapid AST in cases of severe infections, ensuring to saving time and providing, the surveillance of MDR strains and improving stewardship programs.

背景和目的:及时给予适当的抗生素治疗对改善疗效至关重要,尤其是在多药耐药菌株的情况下。尽管表型抗微生物药敏试验(AST)是解决抗生素治疗问题的金标准,但获得负担得起的结果所需的长时间可能会对预后产生负面影响。相反,快速基因型AST为治疗和监测计划提供了必要的信息。为了评估在临床常规中采用快速AST的可能性,我们比较了不同肺炎克雷伯菌菌株的基因型和表型抗菌谱,其特征是碳青霉烯酶编码基因的不同表达。方法:采用Vitek II全自动系统对109株Cr-Kp菌株进行抗菌药物检测,同时采用Etest对新组合的β-内酰胺酶/β-内酶抑制剂(BL/BLI)进行抗菌药物的检测。计算每个菌株的抗微生物耐药性指数(ARI),根据观察到的耐药性/易感性为每个菌株分配1或0分,并将总数除以测试的抗生素数量。Kruskal-Wallis检验,然后是Dunn的事后检验(Bonferroni校正),用于比较抗性基因亚组之间的定量变量。结果:我们在KPC/OXA-48菌株中观察到较高的ARI评分,在单独的KPC和KPC/CTX-M组中观察到相似的情况,在不产生碳青霉烯酶的组中观察出显著较低的耐药性。在BL/BLI的AST中也观察到了同样的趋势。结论:这些初步结果表明基因型和表型AST之间存在密切联系,支持在严重感染病例中采用快速AST,确保节省时间并提供MDR菌株的监测和改进管理计划。
{"title":"Comparison of genotypic and phenotypic antimicrobial profile in carbapenemases producing Klebsiella pneumoniae.","authors":"Arcadia Del Rio, Mariangela Puci, Narcisa Muresu, Illari Sechi, Laura Saderi, Luigi Cugia, Giovanni Sotgiu, Andrea Piana","doi":"10.23750/abm.v94i5.14412","DOIUrl":"10.23750/abm.v94i5.14412","url":null,"abstract":"<p><strong>Background and aim: </strong>Prompt administration of appropriate antibiotic therapy is crucial in improving outcomes, particularly in cases sustained by multi-drug resistant strains. Although phenotypic antimicrobial susceptibility testing (AST) represents the gold standard to address antibiotics treatment, the long time required to obtained affordable results could negatively affect the prognosis. In contrast, rapid genotypic AST provide essential information for treatment and surveillance program. In order to evaluate the potential adoption of rapid AST in clinical routine, we compared the genotypic and phenotypic antimicrobial profiles of different K.pneumoniae strains, characterized by different expression of carbapenemases-encoding genes.</p><p><strong>Methods: </strong>A set of 109 strains of Cr-Kp were tested for the antimicrobial drugs by the automatized Vitek II system and, in parallel, to the new combination of β-lactams/β-lactamases inhibitors (BL/BLI) by Etest. An antimicrobial resistance index (ARI) was calculated for each strain, assigning each 1 or 0 points based on observed resistance/susceptibility, and dividing the total by the number of antibiotics tested. Kruskal-Wallis test, followed by Dunn's post hoc test (Bonferroni correction), were used to compare quantitative variables among resistance gene subgroups.</p><p><strong>Results: </strong>We observed a higher ARI score in KPC/OXA-48 strains, similar profile in KPC alone and KPC/CTX-M groups and a significant lower resistance in no-carbapenemases-producing group. Same trend was observed in AST for BL/BLI.</p><p><strong>Conclusions: </strong>These preliminary results showed a close link between genotypic and phenotypic AST, supporting the adoption of rapid AST in cases of severe infections, ensuring to saving time and providing, the surveillance of MDR strains and improving stewardship programs.</p>","PeriodicalId":93849,"journal":{"name":"Acta bio-medica : Atenei Parmensis","volume":"94 5","pages":"e2023201"},"PeriodicalIF":0.0,"publicationDate":"2023-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644917/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41242010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Acta bio-medica : Atenei Parmensis
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1